Home › Funds › Pacific Life › PD Small-Cap Growth Index Portfolio
Fund family: Pacific Life · Filed by PACIFIC SELECT FUND (CIK 813900) · SEC series S000026038
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 8,310 with, 28 against, 2 abstentions (not counted as with management). Shareholder proposals: 2 FOR, 14 AGAINST, 0 abstained, by the filing’s own vote-source field.
The same two figures as Pacific Life’s manager page (117,487 ballot items across 34 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | Pacific Life | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 94.3% | 8,050 | 94.1% | 100,007 |
| Backed environmental and social shareholder proposals at US companies | n/a | 4 | 3.0% | 810 |
Each ballot item this fund voted is set against the votes of the other Pacific Life funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted differently from most Pacific Life funds on 1 item (0.1% of the 4,235 items where a comparison was possible).
| Company | Meeting | Item | This fund | Most Pacific Life funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| Apogee Therapeutics, Inc. | 2026-06-09 | Election of Class III Directors for terms expiring in 2029: William (BJ) Jones, Jr. | Withhold | FOR — 2 of 3 Pacific Life funds | Against | Passed (calculated), 81.5% support |
Download all 1 differences (CSV)
The same votes as “with management” above, by the sector of the company voted on. 90.2% of this fund’s 8,340 such votes could be given a sector; the other 819 (9.8%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Health Care | 1,832 | 10 | 0.5% |
| Consumer Discretionary | 1,370 | 7 | 0.5% |
| Finance | 1,190 | 0 | 0.0% |
| Technology | 1,057 | 3 | 0.3% |
| Industrials | 912 | 3 | 0.3% |
| Real Estate | 234 | 0 | 0.0% |
| Energy | 223 | 0 | 0.0% |
| Miscellaneous | 169 | 0 | 0.0% |
| Utilities | 169 | 0 | 0.0% |
| Telecommunications | 124 | 1 | 0.8% |
| Basic Materials | 123 | 0 | 0.0% |
| Consumer Staples | 118 | 3 | 2.5% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 5,571 | 11 |
| Audit-related | 1,034 | 0 |
| Say-on-Pay | 1,013 | 2 |
| Compensation | 353 | 0 |
| Corporate Governance | 242 | 8 |
| Capital Structure | 116 | 2 |
| Extraordinary Transactions | 96 | 0 |
| Shareholder Rights and Defenses | 20 | 1 |
| Other | 10 | 0 |
| Diversity, Equity, and Inclusion | 2 | 2 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Bloom Energy Corporation | May 21, 2026 | $3M | 8 | 0 |
| agilon health, inc. | March 17, 2026 | $3M | 2 | 0 |
| Guardant Health, Inc. | June 17, 2026 | $1M | 5 | 0 |
| Glaukos Corporation | May 28, 2026 | $1M | 4 | 0 |
| The Ensign Group, Inc. | May 13, 2026 | $956,585 | 6 | 0 |
| BridgeBio Pharma, Inc. | June 22, 2026 | $909,367 | 7 | 0 |
| Watts Water Technologies, Inc. | May 19, 2026 | $864,993 | 11 | 0 |
| Rambus Inc. | April 23, 2026 | $774,957 | 6 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| April 28, 2026 | The Brink's Company | Act upon a shareholder proposal requesting a report on employee retention rates by demographic categories. Shareholder proposal | Against | For |
| May 20, 2026 | Lumen Technologies, Inc. | Approval of a shareholder proposal regarding a shareholder right to vote for or against a poison pill. Shareholder proposal | Against | For |
| May 13, 2026 | ICU Medical, Inc. | To approve, on an advisory basis, a stockholder proposal to establish a 10% stockholder special meeting right. Shareholder proposal | Against | For |
| March 9, 2026 | Sanmina Corporation | To consider and vote upon the stockholder proposal entitled "Independent Board Chairman," requesting that the Board of Directors adopt a policy and amend governing documents as necessary in order that two separate people hold the office of the Chairman and the office of the CEO. Shareholder proposal | Against | For |
| May 7, 2026 | Wolverine World Wide, Inc. | Shareholder proposal regarding new climate change polices or practices. Shareholder proposal | Against | For |
| May 14, 2026 | Calix, Inc. | To hold an advisory vote on a stockholder proposal relating to a simple majority vote. Shareholder proposal | For | Against |
| June 3, 2026 | Power Integrations, Inc. | To consider, if properly presented at the Annual Meeting, a stockholder proposal related to the separation of the office of Chairman of the Board and the office of Chief Executive Officer. Shareholder proposal | Against | For |
| May 12, 2026 | Group 1 Automotive, Inc. | Shareholder Proposal: Give Shareholders an Ability to Call for a Special Shareholder Meeting. Shareholder proposal | Against | For |
| July 11, 2025 | Brookdale Senior Living Inc. | Election of Directors: Ortelius Nominees OPPOSED by the Company: Steven J. Insoft Shareholder proposal | Withhold | For |
| July 11, 2025 | Brookdale Senior Living Inc. | Election of Directors: Ortelius Nominees OPPOSED by the Company: Paula J. Poskon Shareholder proposal | Withhold | For |
| April 22, 2026 | Bloomin' Brands, Inc. | Stockholder Proposal Regarding Disclosure of Employee Retention Demographics Shareholder proposal | Against | For |
| April 22, 2026 | Bloomin' Brands, Inc. | Stockholder Proposal Regarding the Issuance of "Blank-Check" Preferred Stock Shareholder proposal | Against | For |
Meetings with a proxy contest or competing nominees (8 in 2025-2026), and how the fund voted the items on its ballot.
8,460 ballot items at 1,143 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, PD Small-Cap Growth Index Portfolio voted at 1,143 shareholder meetings of 1,077 companies, on 8,460 ballot items in all. Where management made a recommendation, the fund followed it on 99.6% of the items and voted against it 28 times. Its most frequent area of disagreement was director elections (11 of its votes against management). It voted on 27 shareholder proposals. It voted FOR the board's own proposals about as often as Pacific Life's funds as a whole (94.3% against 94.1%). It voted differently from most Pacific Life funds on 1 item. 8 of its meetings were contested.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Pacific Life’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.